← SynDRA
DAPH
SynDRA canonical compound SYN0000214 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | EGFR |
|---|
| Mechanism of action | EGFR inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- APP
- USP1
- THPO
- TDP1
- SRC
- SMN1
- RGS4
- POLI
- PMP22
- PIN1
- NPSR1
- NFKB1
- NFE2L2
- MPHOSPH8
- MAPT
- MAPK1
- LMNA
- KDM4E
- KCNH2
- HPGD
- HDAC6
- GMNN
- GLA
- EHMT2
- CYP3A4
- CBX1
- BLM
- ATXN2
- ATAD5
- ARSA
- VDR
Cross-references
Synonyms
- CGP-52411
- 4,5-Dianilinophthalimide
- Cgp-52411
- 5,6-Bis(phenylamino)-1H-isoindole-1,3(2H)-dione
- 1H-Isoindole-1,3(2H)-dione, 5,6-bis(phenylamino)-
- J587.895K
- Z13D008FZ2
- CHEBI:53110
- RefChem:96433
- DTXCID2020393
- DAPH1
- CGP52411
- 5,6-Bis(phenylamino)isoindoline-1,3-dione
- 5,6-dianilinoisoindole-1,3-dione
- 5,6-dianilino-1h-isoindole-1,3(2h)-dione
- 5,6-dianilinoisoindoline-1,3-dione
- DAPH-1
- SCHEMBL11017
- 4,5-Bis(anilino)phthalimide
- DAPH-1?
- UNII-Z13D008FZ2
- 4,5-bis-(anilino)phthalimide
- orb1710075
- HMS3260P13
- HMS3413J22
- HMS3677J22
- VFA91558
- Tox21_500236
- BDBM50040929
- DAPH, >=98% (HPLC), solid
- EX-A14448
- MFCD00236442
- AKOS024457581
- CCG-221540
- LP00236
- SB66268
- SDCCGSBI-0633694.P001
- NCGC00093700-01
- NCGC00093700-02
Look up DAPH in the interactive SynDRA portal →